An high-performance liquid chromatographic analysis of PCF 39, N2-[5-(hypoxanthin-9-yl)pentyloxycarbonyl]-L-arginine, with ultraviolet detection, has been devised and validated. The main pharmacokinetic results encountered for rats treated intravenously with PCF 39 at a dose of 100 mg/kg are described.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0021-9673(01)83576-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!